Eli Lilly announced that Retatrutidethe first-in-class GIP, GLP-1, and glucagon triple agonistachieved an average weight loss of 28.7% at 68 weeks in the TRIUMPH-4 Phase 3 trial
As the dosage increases over time, the appetite-suppressing effects often become stronger and more consistent, helping patients develop healthier eating habits and steady progress toward their weight-loss goals
HGH stimulates IGF-1 production in the liver, and insulin plays a role in this process
However, there may be some exceptions where certain insurance plans cover compounded semaglutide under specific circumstances, such as when there is a short supply of the FDA-approved versions
Several practical and clinical factors should inform your decision about when to administer your GLP-1 medication
However, the Cleveland Clinic Journal of Medicine 30 positions that the benefits of GLP-1 medications outweigh the risks and until more is known, there's little reason to withhold use unless coming from a personal or family history of medullary or follicular thyroid cancers
